Implementation Study on Medication Reconciliation Among Pharmacists in Two Tertiary Hospitals in Southwestern Nigeria

Sponsor

University of Ibadan (Other)

Overall Status

Unknown status

CT.gov ID

NCT03182972

Collaborator

(none)

1,000

Enrollment

Locations

Arms

32.9

Anticipated Duration (Months)

500

Patients Per Site

15.2

Patients Per Site Per Month

Study Details

Study Description

Brief Summary

This study will assess the current practice of medication reconciliation among pharmacists in the selected institutions with a view to making an intervention to address gaps discovered

Condition or Disease	Intervention/Treatment	Phase
Intervention Study	Other: Medication reconciliation	N/A

Detailed Description

Background information garnering will be done among the pharmacists in the two selected hospitals to collect data on current practice of medication reconciliation. Focus group discussion will be done in the intervention group so as to identify peculiarities of their practice and to provide the best approach to carrying out the intervention. Diabetes and hypertensive patients in medical outpatient clinic will be interviewed in order to assess current practice of medication reconciliation.

Intervention will be channeled towards addressing gaps discovered. University College Hospital, Ibadan, Oyo State will be the intervention group, while University of Ilorin Teaching Hospital, Kwara State will be the control group.

The effect of the intervention will be measured over time to ensure that medication reconciliation is implemented in the selected institutions.

Study Design

Study Type:

Interventional

Anticipated Enrollment :

1000 participants

Allocation:

Randomized

Intervention Model:

Parallel Assignment

Intervention Model Description:

University College Hospital, Ibadan will serve as the intervention group while University of Ilorin Teaching Hospital, Ilorin will serve as the control group.University College Hospital, Ibadan will serve as the intervention group while University of Ilorin Teaching Hospital, Ilorin will serve as the control group.

Masking:

Double (Participant, Care Provider)

Masking Description:

Both the patients and the pharmacists recruited for the study will not be informed whether they are in the control or intervention group

Primary Purpose:

Health Services Research

Official Title:

Implementation Study on Medication Reconciliation Among Pharmacists in Two Tertiary Hospitals in Nigeria

Actual Study Start Date :

Aug 2, 2016

Anticipated Primary Completion Date :

Apr 30, 2019

Anticipated Study Completion Date :

Apr 30, 2019

Arms and Interventions

Arm	Intervention/Treatment
Experimental: Intervention arm Seminar presentation will be done using the followings: Power point presentation on the following topics as it relates to medication reconciliation: Communication skill (with patients and also with other members of the healthcare team) Documentation of pharmaceutical care activities Medication history taking Drug therapy problems Medication reconciliation practice Case studies on medication reconciliation Role plays on medication reconciliation	Other: Medication reconciliation Pre-post intervention
No Intervention: Control arm Control group

Arm

Intervention/Treatment

Experimental: Intervention arm

Seminar presentation will be done using the followings: Power point presentation on the following topics as it relates to medication reconciliation: Communication skill (with patients and also with other members of the healthcare team) Documentation of pharmaceutical care activities Medication history taking Drug therapy problems Medication reconciliation practice Case studies on medication reconciliation Role plays on medication reconciliation

Other: Medication reconciliation

Pre-post intervention

No Intervention: Control arm

Control group

Outcome Measures

Primary Outcome Measures

Medication reconciliation: Percentage unreconciled medications [3 months]
Percentage unreconciled medications

Eligibility Criteria

Criteria

Ages Eligible for Study:

18 Years and Older

Sexes Eligible for Study:

All

Accepts Healthy Volunteers:

Yes

Inclusion Criteria:

Participant has diabetes and/or hypertension
Registered pharmacists in the selected institutions

Exclusion Criteria:

Participants that are neither diabetic nor hypertensive
Unregistered pharmacists in the selected institutions

Contacts and Locations

Locations

	Site	City	State	Country	Postal Code
1	University of Ilorin Teaching Hospital	Ilorin	Kwara	Nigeria
2	University College Hospital	Ibadan	Oyo	Nigeria	2334

Sponsors and Collaborators

University of Ibadan

Investigators

Study Director: TITILAYO O FAKEYE, PhD, University of Ibadan

Study Documents (Full-Text)

None provided.

More Information

Publications

None provided.

Responsible Party:

AKINNIYI AKINBIYI AJE, Lecturer II, University of Ibadan

ClinicalTrials.gov Identifier:

NCT03182972

Other Study ID Numbers:

MR/UCH/FMC/73247

First Posted:

Jun 9, 2017

Last Update Posted:

Apr 17, 2019

Last Verified:

Apr 1, 2019

Individual Participant Data (IPD) Sharing Statement:

Yes

Plan to Share IPD:

Yes

Studies a U.S. FDA-regulated Drug Product:

Studies a U.S. FDA-regulated Device Product:

Keywords provided by AKINNIYI AKINBIYI AJE, Lecturer II, University of Ibadan

intervention study

medication reconciliation

Study Results

No Results Posted as of Apr 17, 2019